loadpatents
name:-0.047526836395264
name:-0.035130977630615
name:-0.0072541236877441
Xu; Jean Patent Filings

Xu; Jean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Xu; Jean.The latest application filed is for "methods for lowering blood glucose".

Company Profile
7.53.56
  • Xu; Jean - Skillman NJ
  • Xu; Jean - Warren NJ
  • Xu; Jean - Raritan NJ
  • Xu; Jean - Hillsborough NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Lowering Blood Glucose
App 20220296653 - Xu; Jean
2022-09-22
Methods for lowering blood glucose
Grant 11,369,642 - Xu June 28, 2
2022-06-28
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20220125797 - Cohen; Benjamin M. ;   et al.
2022-04-28
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 11,241,439 - Cohen , et al. February 8, 2
2022-02-08
Forms And Compositions Of A Mk2 Inhibitor
App 20210198276 - Han; Jianxin ;   et al.
2021-07-01
Forms and compositions of a MK2 inhibitor
Grant 10,882,867 - Han , et al. January 5, 2
2021-01-05
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20200360395 - Cohen; Benjamin M. ;   et al.
2020-11-19
Use Of Noggin, An Alk5 Inhibitor And A Protein Kinase C Activator, To Produce Endocrine Cells
App 20200291360 - Xu; Jean
2020-09-17
Use of noggin, an ALK5 inhibitor and a protein kinase c activator to produce endocrine cells
Grant 10,704,025 - Xu
2020-07-07
Forms And Compositions Of A Mk2 Inhibitor
App 20200148701 - Han; Jianxin ;   et al.
2020-05-14
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
Grant 10,596,180 - Cohen , et al.
2020-03-24
Differentiation Of Human Embryonic Stem Cells
App 20200048614 - Rezania; Alireza ;   et al.
2020-02-13
Pancreatic Endocrine Cells And Methods Thereof
App 20200030383 - Xu; Jean
2020-01-30
Methods For Lowering Blood Glucose
App 20200030382 - Xu; Jean
2020-01-30
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-- trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use
Grant 10,513,519 - Chen , et al. Dec
2019-12-24
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions
App 20190365772 - Cohen; Benjamin M. ;   et al.
2019-12-05
Lowering blood glucose
Grant 10,471,104 - Xu Nov
2019-11-12
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 10,463,672 - Cohen , et al. No
2019-11-05
Pancreatic endocrine cells and methods thereof
Grant 10,456,424 - Xu Oc
2019-10-29
Forms and compositions of an ERK inhibitor
Grant 10,202,364 - Ferretti , et al. Feb
2019-02-12
Differentiation Of Human Embryonic Stem Cells
App 20190030086 - Xu; Jean
2019-01-31
Solid Forms Of (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-- Trichlorophenyl)amino)-9h-purin-9-yl)-1-methylcyclohexane-1-carboxamide And Methods Of Their Use
App 20180362529 - Chen; Zheng ;   et al.
2018-12-20
Forms And Compositions Of An Erk Inhibitor
App 20180362498 - Ferretti; Antonio Christian ;   et al.
2018-12-20
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20180305333 - Muller; George W. ;   et al.
2018-10-25
Differentiation of human embryonic stem cells
Grant 10,076,544 - Xu September 18, 2
2018-09-18
Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-- trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use
Grant 10,047,090 - Chen , et al. August 14, 2
2018-08-14
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20180200255 - Cohen; Benjamin M. ;   et al.
2018-07-19
Forms and compositions of an ERK inhibitor
Grant 10,005,760 - Ferretti , et al. June 26, 2
2018-06-26
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 9,969,713 - Muller , et al. May 15, 2
2018-05-15
PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE
App 20180042924 - Menon; Anil ;   et al.
2018-02-15
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 9,884,062 - Cohen , et al. February 6, 2
2018-02-06
Differentiation Of Human Embryonic Stem Cells
App 20170354690 - Xu; Jean
2017-12-14
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20170342050 - Muller; George W. ;   et al.
2017-11-30
Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyr- azino[2,3-b]pyrazin-2(1H)-one
Grant 9,827,243 - Kreilein , et al. November 28, 2
2017-11-28
Differentiation of Human Embryonic Stem Cells
App 20170335289 - Rezania; Alireza ;   et al.
2017-11-23
Differentiation Of Human Embryonic Stem Cells
App 20170327793 - Xu; Jean
2017-11-16
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, compositions thereof and methods of their use
Grant 9,814,713 - Man , et al. November 14, 2
2017-11-14
Solid Forms Of (1s,4s)-4-(2-(((3s,4r)-3-fluorotetrahydro-2h-pyran-4-yl)amino)-8-((2,4,6-- Trichlorophenyl)amino)-9h-purin-9-yl)-1-methylcyclohexane-1-carboxamide And Methods Of Their Use
App 20170283418 - Chen; Zheng ;   et al.
2017-10-05
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20170258803 - Cohen; Benjamin M. ;   et al.
2017-09-14
Differentiation of human embryonic stem cells
Grant 9,752,125 - Xu September 5, 2
2017-09-05
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 9,751,853 - Muller , et al. September 5, 2
2017-09-05
Differentiation of human embryonic stem cells
Grant 9,744,195 - Xu August 29, 2
2017-08-29
Forms And Compositions Of An Erk Inhibitor
App 20170226083 - Ferretti; Antonio Christian ;   et al.
2017-08-10
Differentiation of human embryonic stem cells
Grant 9,725,699 - Rezania , et al. August 8, 2
2017-08-08
Differentiation Of Human Embryonic Stem Cells
App 20170183630 - Xu; Jean
2017-06-29
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- e-2,6-dione and compositions comprising and methods of using the same
Grant 9,629,849 - Cohen , et al. April 25, 2
2017-04-25
Differentiation of human embryonic stem cells
Grant 9,593,310 - Xu March 14, 2
2017-03-14
Solid Forms Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide, Compositions Thereof And Methods Of Their Use
App 20160256459 - Man; Hon-Wah ;   et al.
2016-09-08
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione, compositions thereof, and uses thereof
Grant 9,433,606 - Muller , et al. September 6, 2
2016-09-06
PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE
App 20160250210 - Menon; Anil ;   et al.
2016-09-01
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use
Grant 9,403,829 - Connolly , et al. August 2, 2
2016-08-02
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20160214957 - MULLER; George W. ;   et al.
2016-07-28
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, compositions thereof and methods of their use
Grant 9,365,524 - Man , et al. June 14, 2
2016-06-14
Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyr- azino[2,3-b] pyrazin-2(1H)-one
Grant 9,359,364 - Menon , et al. June 7, 2
2016-06-07
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20160136174 - COHEN; Benjamin M. ;   et al.
2016-05-19
Differentiation of Human Embryonic Stem Cells
App 20160032250 - Xu; Jean
2016-02-04
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 9,249,121 - Muller , et al. February 2, 2
2016-02-02
Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dion- e and compositions comprising and methods of using the same
Grant 9,221,788 - Cohen , et al. December 29, 2
2015-12-29
Differentiation of Human Embryonic Stem Cells
App 20150290249 - Xu; Jean
2015-10-15
Differentiation of human embryonic stem cells
Grant 9,150,833 - Xu October 6, 2
2015-10-06
Differentiation of human embryonic stem cells
Grant 9,096,832 - Xu August 4, 2
2015-08-04
Solid Forms Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide, Compositions Thereof And Methods Of Their Use
App 20150210650 - Ferretti; Antonio Christian ;   et al.
2015-07-30
Solid forms of 3-(4-nitro-1-oxisoindolin-2-yl)piperidine-2,6-dione
Grant 9,085,551 - Li , et al. July 21, 2
2015-07-21
Solid Forms Comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- Soindoline-1,3-dione, Compositions Thereof, And Uses Thereof
App 20150196535 - MULLER; George W. ;   et al.
2015-07-16
Differentiation of Human Embryonic Stem Cells
App 20150159139 - Rezania; Alireza ;   et al.
2015-06-11
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione, compositions thereof, and uses thereof
Grant 9,018,243 - Muller , et al. April 28, 2
2015-04-28
Solid Forms Of 3-(4-nitro-1-oxoisoindolin-2-yl)piperidine-2,6-dione
App 20150094473 - Li; Ying ;   et al.
2015-04-02
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20140378484 - MULLER; George W. ;   et al.
2014-12-25
PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYR- AZINO[2,3-b]PYRAZIN-2(1H)-ONE
App 20140315908 - Menon; Anil ;   et al.
2014-10-23
Solid forms of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
Grant 8,802,685 - Muller , et al. August 12, 2
2014-08-12
Differentiation of human embryonic stem cells
Grant 8,785,185 - Xu , et al. July 22, 2
2014-07-22
Differentiation of human embryonic stem cells
Grant 8,785,184 - Xu July 22, 2
2014-07-22
Differentiation of pluripotent stem cells to definitive endoderm lineage
Grant 8,741,643 - Rezania , et al. June 3, 2
2014-06-03
Solid Forms Comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- Soindoline-1,3-dione, Compositions Thereof, And Uses Thereof
App 20140100259 - MULLER; George W. ;   et al.
2014-04-10
Salts And Solid Forms Of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidin- E-2,6-dione And Compositions Comprising And Methods Of Using The Same
App 20140046057 - Cohen; Benjamin M. ;   et al.
2014-02-13
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione, compositions thereof, and uses thereof
Grant 8,629,173 - Muller , et al. January 14, 2
2014-01-14
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses
App 20120232100 - Muller; George ;   et al.
2012-09-13
Solid Forms Comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-y- Lamino]-cyclohexan-1-ol, Compositions Thereof, And Uses Therewith
App 20120115890 - Beauchamps; Marie G. ;   et al.
2012-05-10
Solid Forms Comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- Soindoline-1,3-dione, Compositions Thereof, And Uses Thereof
App 20120101144 - Muller; George W. ;   et al.
2012-04-26
Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-y- lamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
Grant 8,158,635 - Beauchamps , et al. April 17, 2
2012-04-17
Treatment of Diabetes with Pancreatic Endocrine Precursor Cells
App 20120039955 - XU; JEAN
2012-02-16
Solid forms comprising (+)-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisi- noline-1,3-dione, compositions thereof, and uses thereof
Grant 8,093,283 - Muller , et al. January 10, 2
2012-01-10
Differentiation of Human Embryonic Stem Cells
App 20110281355 - XU; JEAN
2011-11-17
Differentiation Of Human Embryonic Stem Cells
App 20110151560 - XU; JEAN
2011-06-23
Solid Forms Comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- Soindoline-1,3-dione, Compositions Thereof, And Uses Thereof
App 20110112307 - MULLER; George W. ;   et al.
2011-05-12
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoi- soindoline-1,3-dione, compositions thereof, and uses thereof
Grant 7,893,101 - Muller , et al. February 22, 2
2011-02-22
Differentiation of Human Embryonic Stem Cells
App 20110014163 - Xu; Jean
2011-01-20
Differentiation of Human Embryonic Stem Cells
App 20110014703 - Xu; Jean ;   et al.
2011-01-20
Differentiation of Human Embryonic Stem Cells
App 20110014702 - XU; JEAN
2011-01-20
Differentiation Of Human Embryonic Stem Cells
App 20100015100 - Xu; Jean
2010-01-21
Solid Forms Comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-y- Lamino]-cyclohexan-1-ol, Compositions Thereof, And Uses Therewith
App 20090048275 - Beauchamps; Marie G. ;   et al.
2009-02-19
Modulation of smooth muscle cell proliferation
Grant 7,482,320 - Geesin , et al. January 27, 2
2009-01-27
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2- methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
App 20080234359 - Muller; George W. ;   et al.
2008-09-25
Differentiation Of Human Embryonic Stem Cells
App 20070254359 - Rezania; Alireza ;   et al.
2007-11-01
Amniotic Fluid Derived Cells
App 20070122903 - Rezania; Alireza ;   et al.
2007-05-31
Compositions and methods to create a vascularized environment for cellular transplantation
App 20070122448 - Rezania; Alireza ;   et al.
2007-05-31
Vascular endothelial growth factor-x
Grant 7,179,890 - Gordon , et al. February 20, 2
2007-02-20
Vascular endothelial growth factor-x
App 20050153882 - Gordon, Robert D. ;   et al.
2005-07-14
Vascular endothelial growth factor-X
Grant 6,783,953 - Gordon , et al. August 31, 2
2004-08-31
Modulation of smooth muscle cell proliferation
App 20040142886 - Geesin, Jeffrey C. ;   et al.
2004-07-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed